These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32804118)

  • 1. Concealed role of red blood cells in pathogenesis of pulmonary arterial hypertension: Decreased red blood cell nitric oxide generation and effect of Rho-Kinase inhibitor fasudil.
    Basarici I; Özen N; Kilavuz E; Kısak F; Basrali F; Yaras N; Koksoy S; Celik ML; Ulker P
    Clin Hemorheol Microcirc; 2020; 76(4):535-548. PubMed ID: 32804118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.
    Raja SG
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):100-4. PubMed ID: 22670803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rho-kinase is a negative regulator of red blood cell eNOS under basal conditions.
    Ulker P; Özen N; Abduleyeva G; Köksoy S; Yaraş N; Basralı F
    Clin Hemorheol Microcirc; 2019; 72(4):407-419. PubMed ID: 30909198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
    Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
    Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension.
    Fujita H; Fukumoto Y; Saji K; Sugimura K; Demachi J; Nawata J; Shimokawa H
    Heart Vessels; 2010 Mar; 25(2):144-9. PubMed ID: 20339976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of Rho-kinase inhibitor fasudil on pulmonary arterial hypertension in patients with congenital heart defects.
    Xiao JW; Zhu XY; Wang QG; Zhang DZ; Cui CS; Zhang P; Chen HY; Meng LL
    Circ J; 2015; 79(6):1342-8. PubMed ID: 25797071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.
    Rashid J; Nahar K; Raut S; Keshavarz A; Ahsan F
    Mol Pharm; 2018 May; 15(5):1755-1765. PubMed ID: 29528655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROCK induced inflammation of the microcirculation during endotoxemia mediated by nitric oxide synthase.
    McGown CC; Brown NJ; Hellewell PG; Brookes ZL
    Microvasc Res; 2011 May; 81(3):281-8. PubMed ID: 21354186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of pulmonary hypertension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil.
    Dai ZK; Wu BN; Chen IC; Chai CY; Wu JR; Chou SH; Yeh JL; Chen IJ; Tan MS
    Pediatr Pulmonol; 2011 Jan; 46(1):45-59. PubMed ID: 20717937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
    Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats.
    Tsounapi P; Saito M; Kitatani K; Dimitriadis F; Ohmasa F; Shimizu S; Kinoshita Y; Takenaka A; Satoh K
    Eur J Pharmacol; 2012 Sep; 691(1-3):182-9. PubMed ID: 22819709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
    Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.
    Fukumoto Y; Tawara S; Shimokawa H
    Tohoku J Exp Med; 2007 Apr; 211(4):309-20. PubMed ID: 17409670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Blood Cell and Endothelial eNOS Independently Regulate Circulating Nitric Oxide Metabolites and Blood Pressure.
    Leo F; Suvorava T; Heuser SK; Li J; LoBue A; Barbarino F; Piragine E; Schneckmann R; Hutzler B; Good ME; Fernandez BO; Vornholz L; Rogers S; Doctor A; Grandoch M; Stegbauer J; Weitzberg E; Feelisch M; Lundberg JO; Isakson BE; Kelm M; Cortese-Krott MM
    Circulation; 2021 Sep; 144(11):870-889. PubMed ID: 34229449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide does not downregulate Rho-kinase (ROCK-2) expression in rat coronary endothelial cells.
    Tiftik RN; Erol A; Cnar MG; Kubat H; Ark M; Ulker S; Büyükafşar K
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):140-7. PubMed ID: 18287881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the RhoA-ROCK pathway to regulate T-cell homeostasis in hypoxia-induced pulmonary arterial hypertension.
    Li C; Liu PP; Tang DD; Song R; Zhang YQ; Lei S; Wu SJ
    Pulm Pharmacol Ther; 2018 Jun; 50():111-122. PubMed ID: 29673911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Rho-kinase signaling and endothelial dysfunction in modulating blood flow distribution in pulmonary hypertension.
    Schwenke DO; Pearson JT; Sonobe T; Ishibashi-Ueda H; Shimouchi A; Kangawa K; Umetani K; Shirai M
    J Appl Physiol (1985); 2011 Apr; 110(4):901-8. PubMed ID: 21212241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.
    Takemoto M; Sun J; Hiroki J; Shimokawa H; Liao JK
    Circulation; 2002 Jul; 106(1):57-62. PubMed ID: 12093770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.
    Hofni A; Shehata Messiha BA; Mangoura SA
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Aug; 390(8):801-811. PubMed ID: 28493050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.